NCT04699292招募中不适用
International Prospective Registry on Local Treatment Approaches in Myxoid Liposarcomas
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Local recurrence free survival
研究概览
简要总结
To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)
详细描述
In order to confirm the promising results of the 36 Gy dose level in the DOREMY trial (NCT02106312) and to compare outcome with other local treatment approaches.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age > 18 years
- •Biopsy proven MLS, including the reciprocal chromosomal translocation t(12;16)(q13;p11)
- •ECOG PS 0-2
- •Written informed consent to share coded information in this international Registry
排除标准
- •Prior radiotherapy to the target area
- •Pregnancy
结局指标
主要结局
Local recurrence free survival
时间窗: From surgery to the end of at least 5 years of follow-up
Survival from surgery to local recurrence (event) or last follow-up
次要结局
- Wound complications(From surgery to 6 months of follow-up)
- Late toxicity(From 3 months after surgery to the end of at least 5 years of follow-up)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
INVEST-REGISTRY: Minimally Invasive Endoscopic Surgical Treatment With Apollo/Artemis in Patients With Brain HemorrhageIntracranial HemorrhageNCT02661672J. Mocco38
进行中(未招募)
不适用
A Registry of Laparoscopic Bariatric Surgery Using Stapling Devices: Observation of Safety and Clinical EfficacyRoux-en-Y Gastric BypassGastrostomyNissen SleeveObesityNCT04808206Duomed150
已完成
不适用
Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR MutationsOligometastatic Lung AdenocarcinomaNCT02450591Memorial Sloan Kettering Cancer Center4
已完成
不适用
Lymphangioleiomyomatosis (LAM) RegistryLung DiseasesLymphangiomyomatosisNCT00005486National Heart, Lung, and Blood Institute (NHLBI)
已完成
3 期
Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)Carcinoma, Adrenal CorticalNCT00094497Collaborative Group for Adrenocortical Carcinoma Treatment304
